Tag:
OctoPlus
Latest Headlines
Latest Headlines
OctoPlus tries to get drug-delivery tentacles into generics
OctoPlus, a drug-delivery company based in the Netherlands, is actively looking for partnerships with specialty manufacturers of generic drugs, which OctoPlus believes can benefit from its
OctoPlus snares a 'top 5' pharma firm for PolyActive tech
OctoPlus, based in the Netherlands, says its PolyActive brand of controlled-release technology has an extensive safety record and makes an "excellent technology for the controlled release of proteins
OctoPlus strikes delivery tech development pact with Novartis
Dutch biotech OctoPlus has struck a deal to use its controlled release technology to formulate a new compound for Novartis. The pact will put OctoPlus's drug delivery technology PolyActive to work on
OctoPlus axes 25% of its staff in streamlining
The Dutch biotech OctoPlus is axing a quarter of its staff, shedding costs while it focuses on advancing its drug delivery technology. OctoPlus is using new controlled-release technology to design
OctoPlus lands formulation work
Netherlands-based drug-delivery specialist OctoPlus will perform formulation development and clinical manufacturing for an unnamed mid-sized European drug maker. The work encompasses three products,
Biolex gains $60M in VC cash, inks licensing deal
Just seven months after dropping its IPO plans in a brutal market environment, Biolex Therapeutics
Turbulent market forces Biolex to scrap IPO
The turbulent stock market has claimed another biotech victim. Biolex Therapeutics says it is dropping its bid to go public, the result of some lethal market rip tides that have already spurred more
SPOTLIGHT: OctoPlus reports positive hep C data
Amsterdam-based OctoPlus says that its hepatitis C drug Locteron demonstrated an antiviral effect in Phase IIa. OctoPlus is developing Locteron with Biolex, which is planning a Phase IIb trial for
